1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Meningitis Vaccine Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Meningitis Vaccine by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Meningitis Vaccine by Country/Region, 2018, 2022 & 2029 2.2 Meningitis Vaccine Segment by Type 2.2.1 Meningitis A+C 2.2.2 Meningitis ACWY135 2.2.3 Meningitis B 2.3 Meningitis Vaccine Sales by Type 2.3.1 Global Meningitis Vaccine Sales Market Share by Type (2018-2023) 2.3.2 Global Meningitis Vaccine Revenue and Market Share by Type (2018-2023) 2.3.3 Global Meningitis Vaccine Sale Price by Type (2018-2023) 2.4 Meningitis Vaccine Segment by Application 2.4.1 Medical Care 2.4.2 Hospital 2.5 Meningitis Vaccine Sales by Application 2.5.1 Global Meningitis Vaccine Sale Market Share by Application (2018-2023) 2.5.2 Global Meningitis Vaccine Revenue and Market Share by Application (2018-2023) 2.5.3 Global Meningitis Vaccine Sale Price by Application (2018-2023) 3 Global Meningitis Vaccine by Company 3.1 Global Meningitis Vaccine Breakdown Data by Company 3.1.1 Global Meningitis Vaccine Annual Sales by Company (2018-2023) 3.1.2 Global Meningitis Vaccine Sales Market Share by Company (2018-2023) 3.2 Global Meningitis Vaccine Annual Revenue by Company (2018-2023) 3.2.1 Global Meningitis Vaccine Revenue by Company (2018-2023) 3.2.2 Global Meningitis Vaccine Revenue Market Share by Company (2018-2023) 3.3 Global Meningitis Vaccine Sale Price by Company 3.4 Key Manufacturers Meningitis Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Meningitis Vaccine Product Location Distribution 3.4.2 Players Meningitis Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Meningitis Vaccine by Geographic Region 4.1 World Historic Meningitis Vaccine Market Size by Geographic Region (2018-2023) 4.1.1 Global Meningitis Vaccine Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Meningitis Vaccine Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Meningitis Vaccine Market Size by Country/Region (2018-2023) 4.2.1 Global Meningitis Vaccine Annual Sales by Country/Region (2018-2023) 4.2.2 Global Meningitis Vaccine Annual Revenue by Country/Region (2018-2023) 4.3 Americas Meningitis Vaccine Sales Growth 4.4 APAC Meningitis Vaccine Sales Growth 4.5 Europe Meningitis Vaccine Sales Growth 4.6 Middle East & Africa Meningitis Vaccine Sales Growth 5 Americas 5.1 Americas Meningitis Vaccine Sales by Country 5.1.1 Americas Meningitis Vaccine Sales by Country (2018-2023) 5.1.2 Americas Meningitis Vaccine Revenue by Country (2018-2023) 5.2 Americas Meningitis Vaccine Sales by Type 5.3 Americas Meningitis Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Meningitis Vaccine Sales by Region 6.1.1 APAC Meningitis Vaccine Sales by Region (2018-2023) 6.1.2 APAC Meningitis Vaccine Revenue by Region (2018-2023) 6.2 APAC Meningitis Vaccine Sales by Type 6.3 APAC Meningitis Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Meningitis Vaccine by Country 7.1.1 Europe Meningitis Vaccine Sales by Country (2018-2023) 7.1.2 Europe Meningitis Vaccine Revenue by Country (2018-2023) 7.2 Europe Meningitis Vaccine Sales by Type 7.3 Europe Meningitis Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Meningitis Vaccine by Country 8.1.1 Middle East & Africa Meningitis Vaccine Sales by Country (2018-2023) 8.1.2 Middle East & Africa Meningitis Vaccine Revenue by Country (2018-2023) 8.2 Middle East & Africa Meningitis Vaccine Sales by Type 8.3 Middle East & Africa Meningitis Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Meningitis Vaccine 10.3 Manufacturing Process Analysis of Meningitis Vaccine 10.4 Industry Chain Structure of Meningitis Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Meningitis Vaccine Distributors 11.3 Meningitis Vaccine Customer 12 World Forecast Review for Meningitis Vaccine by Geographic Region 12.1 Global Meningitis Vaccine Market Size Forecast by Region 12.1.1 Global Meningitis Vaccine Forecast by Region (2024-2029) 12.1.2 Global Meningitis Vaccine Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Meningitis Vaccine Forecast by Type 12.7 Global Meningitis Vaccine Forecast by Application 13 Key Players Analysis 13.1 GlaxoSmithKline 13.1.1 GlaxoSmithKline Company Information 13.1.2 GlaxoSmithKline Meningitis Vaccine Product Portfolios and Specifications 13.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 GlaxoSmithKline Main Business Overview 13.1.5 GlaxoSmithKline Latest Developments 13.2 Baxter International 13.2.1 Baxter International Company Information 13.2.2 Baxter International Meningitis Vaccine Product Portfolios and Specifications 13.2.3 Baxter International Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Baxter International Main Business Overview 13.2.5 Baxter International Latest Developments 13.3 Sanofi Pasteur 13.3.1 Sanofi Pasteur Company Information 13.3.2 Sanofi Pasteur Meningitis Vaccine Product Portfolios and Specifications 13.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Sanofi Pasteur Main Business Overview 13.3.5 Sanofi Pasteur Latest Developments 13.4 Merck 13.4.1 Merck Company Information 13.4.2 Merck Meningitis Vaccine Product Portfolios and Specifications 13.4.3 Merck Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Merck Main Business Overview 13.4.5 Merck Latest Developments 13.5 Novartis 13.5.1 Novartis Company Information 13.5.2 Novartis Meningitis Vaccine Product Portfolios and Specifications 13.5.3 Novartis Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Novartis Main Business Overview 13.5.5 Novartis Latest Developments 13.6 Pfizer 13.6.1 Pfizer Company Information 13.6.2 Pfizer Meningitis Vaccine Product Portfolios and Specifications 13.6.3 Pfizer Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Pfizer Main Business Overview 13.6.5 Pfizer Latest Developments 13.7 Hualan 13.7.1 Hualan Company Information 13.7.2 Hualan Meningitis Vaccine Product Portfolios and Specifications 13.7.3 Hualan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Hualan Main Business Overview 13.7.5 Hualan Latest Developments 13.8 Zhejiang Tianyuan 13.8.1 Zhejiang Tianyuan Company Information 13.8.2 Zhejiang Tianyuan Meningitis Vaccine Product Portfolios and Specifications 13.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Zhejiang Tianyuan Main Business Overview 13.8.5 Zhejiang Tianyuan Latest Developments 13.9 Beijing Tiantan Biological 13.9.1 Beijing Tiantan Biological Company Information 13.9.2 Beijing Tiantan Biological Meningitis Vaccine Product Portfolios and Specifications 13.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Beijing Tiantan Biological Main Business Overview 13.9.5 Beijing Tiantan Biological Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Meningitis Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Meningitis Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Meningitis A+C Table 4. Major Players of Meningitis ACWY135 Table 5. Major Players of Meningitis B Table 6. Global Meningitis Vaccine Sales by Type (2018-2023) & (K MT) Table 7. Global Meningitis Vaccine Sales Market Share by Type (2018-2023) Table 8. Global Meningitis Vaccine Revenue by Type (2018-2023) & ($ million) Table 9. Global Meningitis Vaccine Revenue Market Share by Type (2018-2023) Table 10. Global Meningitis Vaccine Sale Price by Type (2018-2023) & (USD/MT) Table 11. Global Meningitis Vaccine Sales by Application (2018-2023) & (K MT) Table 12. Global Meningitis Vaccine Sales Market Share by Application (2018-2023) Table 13. Global Meningitis Vaccine Revenue by Application (2018-2023) Table 14. Global Meningitis Vaccine Revenue Market Share by Application (2018-2023) Table 15. Global Meningitis Vaccine Sale Price by Application (2018-2023) & (USD/MT) Table 16. Global Meningitis Vaccine Sales by Company (2018-2023) & (K MT) Table 17. Global Meningitis Vaccine Sales Market Share by Company (2018-2023) Table 18. Global Meningitis Vaccine Revenue by Company (2018-2023) ($ Millions) Table 19. Global Meningitis Vaccine Revenue Market Share by Company (2018-2023) Table 20. Global Meningitis Vaccine Sale Price by Company (2018-2023) & (USD/MT) Table 21. Key Manufacturers Meningitis Vaccine Producing Area Distribution and Sales Area Table 22. Players Meningitis Vaccine Products Offered Table 23. Meningitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Meningitis Vaccine Sales by Geographic Region (2018-2023) & (K MT) Table 27. Global Meningitis Vaccine Sales Market Share Geographic Region (2018-2023) Table 28. Global Meningitis Vaccine Revenue by Geographic Region (2018-2023) & ($ millions) Table 29. Global Meningitis Vaccine Revenue Market Share by Geographic Region (2018-2023) Table 30. Global Meningitis Vaccine Sales by Country/Region (2018-2023) & (K MT) Table 31. Global Meningitis Vaccine Sales Market Share by Country/Region (2018-2023) Table 32. Global Meningitis Vaccine Revenue by Country/Region (2018-2023) & ($ millions) Table 33. Global Meningitis Vaccine Revenue Market Share by Country/Region (2018-2023) Table 34. Americas Meningitis Vaccine Sales by Country (2018-2023) & (K MT) Table 35. Americas Meningitis Vaccine Sales Market Share by Country (2018-2023) Table 36. Americas Meningitis Vaccine Revenue by Country (2018-2023) & ($ Millions) Table 37. Americas Meningitis Vaccine Revenue Market Share by Country (2018-2023) Table 38. Americas Meningitis Vaccine Sales by Type (2018-2023) & (K MT) Table 39. Americas Meningitis Vaccine Sales by Application (2018-2023) & (K MT) Table 40. APAC Meningitis Vaccine Sales by Region (2018-2023) & (K MT) Table 41. APAC Meningitis Vaccine Sales Market Share by Region (2018-2023) Table 42. APAC Meningitis Vaccine Revenue by Region (2018-2023) & ($ Millions) Table 43. APAC Meningitis Vaccine Revenue Market Share by Region (2018-2023) Table 44. APAC Meningitis Vaccine Sales by Type (2018-2023) & (K MT) Table 45. APAC Meningitis Vaccine Sales by Application (2018-2023) & (K MT) Table 46. Europe Meningitis Vaccine Sales by Country (2018-2023) & (K MT) Table 47. Europe Meningitis Vaccine Sales Market Share by Country (2018-2023) Table 48. Europe Meningitis Vaccine Revenue by Country (2018-2023) & ($ Millions) Table 49. Europe Meningitis Vaccine Revenue Market Share by Country (2018-2023) Table 50. Europe Meningitis Vaccine Sales by Type (2018-2023) & (K MT) Table 51. Europe Meningitis Vaccine Sales by Application (2018-2023) & (K MT) Table 52. Middle East & Africa Meningitis Vaccine Sales by Country (2018-2023) & (K MT) Table 53. Middle East & Africa Meningitis Vaccine Sales Market Share by Country (2018-2023) Table 54. Middle East & Africa Meningitis Vaccine Revenue by Country (2018-2023) & ($ Millions) Table 55. Middle East & Africa Meningitis Vaccine Revenue Market Share by Country (2018-2023) Table 56. Middle East & Africa Meningitis Vaccine Sales by Type (2018-2023) & (K MT) Table 57. Middle East & Africa Meningitis Vaccine Sales by Application (2018-2023) & (K MT) Table 58. Key Market Drivers & Growth Opportunities of Meningitis Vaccine Table 59. Key Market Challenges & Risks of Meningitis Vaccine Table 60. Key Industry Trends of Meningitis Vaccine Table 61. Meningitis Vaccine Raw Material Table 62. Key Suppliers of Raw Materials Table 63. Meningitis Vaccine Distributors List Table 64. Meningitis Vaccine Customer List Table 65. Global Meningitis Vaccine Sales Forecast by Region (2024-2029) & (K MT) Table 66. Global Meningitis Vaccine Revenue Forecast by Region (2024-2029) & ($ millions) Table 67. Americas Meningitis Vaccine Sales Forecast by Country (2024-2029) & (K MT) Table 68. Americas Meningitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions) Table 69. APAC Meningitis Vaccine Sales Forecast by Region (2024-2029) & (K MT) Table 70. APAC Meningitis Vaccine Revenue Forecast by Region (2024-2029) & ($ millions) Table 71. Europe Meningitis Vaccine Sales Forecast by Country (2024-2029) & (K MT) Table 72. Europe Meningitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions) Table 73. Middle East & Africa Meningitis Vaccine Sales Forecast by Country (2024-2029) & (K MT) Table 74. Middle East & Africa Meningitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions) Table 75. Global Meningitis Vaccine Sales Forecast by Type (2024-2029) & (K MT) Table 76. Global Meningitis Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions) Table 77. Global Meningitis Vaccine Sales Forecast by Application (2024-2029) & (K MT) Table 78. Global Meningitis Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions) Table 79. GlaxoSmithKline Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 80. GlaxoSmithKline Meningitis Vaccine Product Portfolios and Specifications Table 81. GlaxoSmithKline Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 82. GlaxoSmithKline Main Business Table 83. GlaxoSmithKline Latest Developments Table 84. Baxter International Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 85. Baxter International Meningitis Vaccine Product Portfolios and Specifications Table 86. Baxter International Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 87. Baxter International Main Business Table 88. Baxter International Latest Developments Table 89. Sanofi Pasteur Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 90. Sanofi Pasteur Meningitis Vaccine Product Portfolios and Specifications Table 91. Sanofi Pasteur Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 92. Sanofi Pasteur Main Business Table 93. Sanofi Pasteur Latest Developments Table 94. Merck Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 95. Merck Meningitis Vaccine Product Portfolios and Specifications Table 96. Merck Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 97. Merck Main Business Table 98. Merck Latest Developments Table 99. Novartis Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 100. Novartis Meningitis Vaccine Product Portfolios and Specifications Table 101. Novartis Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 102. Novartis Main Business Table 103. Novartis Latest Developments Table 104. Pfizer Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 105. Pfizer Meningitis Vaccine Product Portfolios and Specifications Table 106. Pfizer Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 107. Pfizer Main Business Table 108. Pfizer Latest Developments Table 109. Hualan Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 110. Hualan Meningitis Vaccine Product Portfolios and Specifications Table 111. Hualan Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 112. Hualan Main Business Table 113. Hualan Latest Developments Table 114. Zhejiang Tianyuan Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 115. Zhejiang Tianyuan Meningitis Vaccine Product Portfolios and Specifications Table 116. Zhejiang Tianyuan Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 117. Zhejiang Tianyuan Main Business Table 118. Zhejiang Tianyuan Latest Developments Table 119. Beijing Tiantan Biological Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 120. Beijing Tiantan Biological Meningitis Vaccine Product Portfolios and Specifications Table 121. Beijing Tiantan Biological Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 122. Beijing Tiantan Biological Main Business Table 123. Beijing Tiantan Biological Latest Developments List of Figures Figure 1. Picture of Meningitis Vaccine Figure 2. Meningitis Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Meningitis Vaccine Sales Growth Rate 2018-2029 (K MT) Figure 7. Global Meningitis Vaccine Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Meningitis Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Meningitis A+C Figure 10. Product Picture of Meningitis ACWY135 Figure 11. Product Picture of Meningitis B Figure 12. Global Meningitis Vaccine Sales Market Share by Type in 2022 Figure 13. Global Meningitis Vaccine Revenue Market Share by Type (2018-2023) Figure 14. Meningitis Vaccine Consumed in Medical Care Figure 15. Global Meningitis Vaccine Market: Medical Care (2018-2023) & (K MT) Figure 16. Meningitis Vaccine Consumed in Hospital Figure 17. Global Meningitis Vaccine Market: Hospital (2018-2023) & (K MT) Figure 18. Global Meningitis Vaccine Sales Market Share by Application (2022) Figure 19. Global Meningitis Vaccine Revenue Market Share by Application in 2022 Figure 20. Meningitis Vaccine Sales Market by Company in 2022 (K MT) Figure 21. Global Meningitis Vaccine Sales Market Share by Company in 2022 Figure 22. Meningitis Vaccine Revenue Market by Company in 2022 ($ Million) Figure 23. Global Meningitis Vaccine Revenue Market Share by Company in 2022 Figure 24. Global Meningitis Vaccine Sales Market Share by Geographic Region (2018-2023) Figure 25. Global Meningitis Vaccine Revenue Market Share by Geographic Region in 2022 Figure 26. Americas Meningitis Vaccine Sales 2018-2023 (K MT) Figure 27. Americas Meningitis Vaccine Revenue 2018-2023 ($ Millions) Figure 28. APAC Meningitis Vaccine Sales 2018-2023 (K MT) Figure 29. APAC Meningitis Vaccine Revenue 2018-2023 ($ Millions) Figure 30. Europe Meningitis Vaccine Sales 2018-2023 (K MT) Figure 31. Europe Meningitis Vaccine Revenue 2018-2023 ($ Millions) Figure 32. Middle East & Africa Meningitis Vaccine Sales 2018-2023 (K MT) Figure 33. Middle East & Africa Meningitis Vaccine Revenue 2018-2023 ($ Millions) Figure 34. Americas Meningitis Vaccine Sales Market Share by Country in 2022 Figure 35. Americas Meningitis Vaccine Revenue Market Share by Country in 2022 Figure 36. Americas Meningitis Vaccine Sales Market Share by Type (2018-2023) Figure 37. Americas Meningitis Vaccine Sales Market Share by Application (2018-2023) Figure 38. United States Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 39. Canada Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 40. Mexico Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 41. Brazil Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 42. APAC Meningitis Vaccine Sales Market Share by Region in 2022 Figure 43. APAC Meningitis Vaccine Revenue Market Share by Regions in 2022 Figure 44. APAC Meningitis Vaccine Sales Market Share by Type (2018-2023) Figure 45. APAC Meningitis Vaccine Sales Market Share by Application (2018-2023) Figure 46. China Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 47. Japan Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 48. South Korea Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 49. Southeast Asia Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 50. India Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 51. Australia Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 52. China Taiwan Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 53. Europe Meningitis Vaccine Sales Market Share by Country in 2022 Figure 54. Europe Meningitis Vaccine Revenue Market Share by Country in 2022 Figure 55. Europe Meningitis Vaccine Sales Market Share by Type (2018-2023) Figure 56. Europe Meningitis Vaccine Sales Market Share by Application (2018-2023) Figure 57. Germany Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 58. France Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 59. UK Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 60. Italy Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 61. Russia Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 62. Middle East & Africa Meningitis Vaccine Sales Market Share by Country in 2022 Figure 63. Middle East & Africa Meningitis Vaccine Revenue Market Share by Country in 2022 Figure 64. Middle East & Africa Meningitis Vaccine Sales Market Share by Type (2018-2023) Figure 65. Middle East & Africa Meningitis Vaccine Sales Market Share by Application (2018-2023) Figure 66. Egypt Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 67. South Africa Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 68. Israel Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 69. Turkey Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 70. GCC Country Meningitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 71. Manufacturing Cost Structure Analysis of Meningitis Vaccine in 2022 Figure 72. Manufacturing Process Analysis of Meningitis Vaccine Figure 73. Industry Chain Structure of Meningitis Vaccine Figure 74. Channels of Distribution Figure 75. Global Meningitis Vaccine Sales Market Forecast by Region (2024-2029) Figure 76. Global Meningitis Vaccine Revenue Market Share Forecast by Region (2024-2029) Figure 77. Global Meningitis Vaccine Sales Market Share Forecast by Type (2024-2029) Figure 78. Global Meningitis Vaccine Revenue Market Share Forecast by Type (2024-2029) Figure 79. Global Meningitis Vaccine Sales Market Share Forecast by Application (2024-2029) Figure 80. Global Meningitis Vaccine Revenue Market Share Forecast by Application (2024-2029)